Thermo Fisher ScientificBSP:TMOS34 +7.04%74 FCF Margin % is 7.41% as of Mar. 2026, which is 54% below its 10-year median of 16.00. GuruFocus rates BSP:TMOS34 with a GF Score™ of 74/100 and a GF Value™ of R$63.08 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Thermo Fisher Scientific ranks better than 83.33% on this metric.
The historical rank and industry rank for Thermo Fisher Scientific's FCF Margin % or its related term are showing as below:
BSP:TMOS34'
s FCF Margin % Range Over the Past 10 Years
Min: 14.12 Med: 16 Max: 21.15
Current: 14.98
During the past 13 years, the highest FCF Margin % of Thermo Fisher Scientific was 21.15%. The lowest was 14.12%. And the median was 16.00%.
BSP:TMOS34's FCF Margin % is ranked better than 83.33% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.845
vs BSP:TMOS34: 14.98
Thermo Fisher Scientific FCF Margin % Related Terms
Thermo Fisher Scientific FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:TMOS34 vs DHR, IDXX, A: FCF Margin % Comparison
For the Diagnostics & Research subindustry, Thermo Fisher Scientific's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thermo Fisher Scientific FCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Thermo Fisher Scientific's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thermo Fisher Scientific (BSP:TMOS34) has a FCF Margin % of 7.41% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Thermo Fisher Scientific and its competitors. This is 54% below median its historical median of 16.00. Over the past decade, Thermo Fisher Scientific's FCF Margin % has ranged from 14.12 to 21.15. According to the industry distribution chart, Thermo Fisher Scientific ranks #34 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 16.7%.
Is Thermo Fisher Scientific's FCF Margin % too high?
Thermo Fisher Scientific's current FCF Margin % of 7.41% is 54% below median its 10-year median of 16.00. Over the past 10 years, this metric has ranged from a low of 14.12 to a high of 21.15. Based on the distribution chart, Thermo Fisher Scientific ranks #34 out of 204 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Thermo Fisher Scientific has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Thermo Fisher Scientific's FCF Margin % compare to DHR and IDXX?
According to the Medical Diagnostics & Research industry distribution chart, Thermo Fisher Scientific ranks #34 out of 204 companies for FCF Margin %. This places Thermo Fisher Scientific in the top 17% of its industry — outperforming the majority of peers. Historically, Thermo Fisher Scientific's own FCF Margin % has ranged from 14.12 to 21.15 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Thermo Fisher Scientific and its competitors. Thermo Fisher Scientific's current FCF Margin % is 7.41%, which is 54% below median its own 10-year median of 16.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thermo Fisher Scientific stock overvalued right now?
Based on GuruFocus' analysis, Thermo Fisher Scientific (BSP:TMOS34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$63.08, compared to a current price of R$53.25 — trading 15.6% below its estimated fair value. The current FCF Margin % is 7.41%, which is 54% below median its 10-year median of 16.00. Thermo Fisher Scientific's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Thermo Fisher Scientific (BSP:TMOS34), the current FCF Margin % is 7.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Thermo Fisher Scientific (BSP:TMOS34) Overvalued in 2026?
Based on GuruFocus' analysis, Thermo Fisher Scientific stock appears to be undervalued.
The current stock price of R$53.25 is trading 15.6% below its estimated GF Value™ of R$63.08.
GuruFocus considers Thermo Fisher Scientific to be Modestly Undervalued.
Key valuation signals for BSP:TMOS34:
FCF Margin %: 7.41% (54% below median its 10-year median of 16.00)
GF Value™: R$63.08 vs. price of R$53.25 (15.6% below fair value)
No single metric tells the full story. See the BSP:TMOS34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
74GF Score
Get the complete analysis for BSP:TMOS34
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:TMOS34 has been successfully added to your 
